Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Yan Li,1 Xiaomin Wang,2 Edward O’Mara,1 Meletios A Dimopoulos,3 Pieter Sonneveld,4 Katja C Weisel,5 Jeffrey Matous,6 David S Siegel,7 Jatin J Shah,8 Elisabeth Kueenburg,9 Lars Sternas,9 Chloe Cavanaugh,9 Mohamed Zaki,9 Maria Palmisano,1 Simon Zhou1 1Translational Development and C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
hemodialysis
pomalidomide
population pharmacokinetics
renal impairment
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/8582ebb39ceb4fcd9b07b7d44a784b3f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/8582ebb39ceb4fcd9b07b7d44a784b3f

Ejemplares similares